Cal-Maine Foods director awarded restricted shares

Cal-Maine Foods director Camille S. Young reported a new stock grant.

Rhea-AI Filing Summary

Cal-Maine Foods director Camille S. Young reported a new stock grant. On January 12, 2026, she received 1,310 shares of Cal-Maine Foods common stock at a price of $0 per share as an award.

The filing explains this is time-vesting restricted stock that will vest on the third anniversary of the grant date. After this award, Young beneficially owns 9,931 shares of Cal-Maine Foods common stock in direct ownership.

Insider Trade Summary

Grant/Award: 1,310 shares

Grant/Award 1 txn

Insider Young Camille S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,310	$0.00	$0.00

Holdings After Transaction: Common Stock — 9,931 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of time-vesting restricted stock, which will vest on the third anniversary of the date of grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CALM director Camille S. Young report?

Camille S. Young, a director of Cal-Maine Foods, reported receiving a grant of 1,310 shares of common stock on January 12, 2026.

Was the CALM transaction a purchase or a stock grant?

The transaction was coded "A" and described as a grant of time-vesting restricted stock, not an open-market purchase.

What type of shares did Camille S. Young receive from Cal-Maine Foods (CALM)?

She received time-vesting restricted common stock, which is subject to vesting conditions over time.

When do the restricted CALM shares granted to Camille S. Young vest?

The restricted stock will vest on the third anniversary of the January 12, 2026 grant date.

How many Cal-Maine Foods (CALM) shares does Camille S. Young own after the grant?

Following the reported transaction, she beneficially owns 9,931 shares of Cal-Maine Foods common stock in direct ownership.

What was the reported price for the CALM restricted stock grant?

The 1,310 restricted shares were reported at a price of $0 per share, reflecting an equity award rather than a cash purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/14/2026 - 04:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Young Camille S

(Last) (First) (Middle)

1052 HIGHLAND COLONY PKWY, SUITE 200

(Street)

RIDGELAND MS 39157

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CAL-MAINE FOODS INC [ CALM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/12/2026		A(1)		1,310	A	$0	9,931	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of time-vesting restricted stock, which will vest on the third anniversary of the date of grant.

Remarks:

	/s/Robert L. Holladay, Jr., on behalf of Camille S. Young, pursuant to a power of attorney	01/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.